Imidazo[4,5-c]pyridine compounds as lsd-1 inhibitors
dc.contributor.author | Wang, shaomeng | |
dc.contributor.author | Rej, rohan | |
dc.coverage.spatial | US | |
dc.date.accessioned | 2022-09-17T01:55:18Z | |
dc.date.available | 2022-09-17T01:55:18Z | |
dc.date.submitted | 2018-05-01 | |
dc.identifier.uri | https://hdl.handle.net/2027.42/174696 | |
dc.description.abstract | The present disclosure provides compounds represented by Formula I: and the pharmaceutically acceptable salts and solvates thereof, wherein R1, R2, R3, and R4 are as defined as set forth in the specification. The present disclosure also provides compounds of Formula I for use to treat a condition or disorder responsive to LSD1 inhibition such as cancer. | |
dc.title | Imidazo[4,5-c]pyridine compounds as lsd-1 inhibitors | |
dc.type | Patent | |
dc.description.bitstreamurl | http://deepblue.lib.umich.edu/bitstream/2027.42/174696/2/83996668_1574652646.pdf | |
dc.identifier.doi | https://dx.doi.org/10.7302/6427 | |
dc.date.updated | 2022-09-17T01:55:16Z | |
dc.identifier.orcid | 0000-0002-8782-6950 | |
dc.identifier.orcid | 0000-0003-0904-9137 | |
dc.identifier.name-orcid | Wang, shaomeng; 0000-0002-8782-6950 | |
dc.identifier.name-orcid | Rej, rohan; 0000-0003-0904-9137 | |
dc.working.doi | 10.7302/6427 | en |
dc.owningcollname | Internal Medicine, Department of |
Files in this item
Remediation of Harmful Language
The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.
Accessibility
If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.